Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women. — CFSMEATLAS
Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
Milrad, Sara F, Hall, Daniel L, Jutagir, Devika R et al. · Journal of neuroimmunology · 2017 · DOI
Quick Summary
This study looked at 60 women with ME/CFS to understand how sleep quality affects their symptoms and inflammation levels. Researchers found that women who slept poorly had higher levels of inflammatory substances in their blood and experienced more severe fatigue and ME/CFS symptoms. The findings suggest that improving sleep quality might help reduce both inflammation and symptom severity in people living with ME/CFS.
Why It Matters
Sleep problems are common and distressing in ME/CFS, but their relationship to inflammation and symptom severity has been under-studied. This research provides empirical evidence linking poor sleep to both inflammatory markers and worse symptoms, supporting sleep management as a potential therapeutic target and justifying further investigation of sleep interventions in ME/CFS care.
Observed Findings
Poor sleep quality was significantly associated with elevated circulating IL-1β, IL-6, and TNF-α levels
Worse sleep quality correlated with greater fatigue severity and fatigue-related interference with daily activities
Poor sleep quality was associated with more severe and more frequent CDC-defined core ME/CFS symptoms
All associations remained significant after controlling for age, education, and body mass index
Inferred Conclusions
Sleep quality represents an important clinical factor in ME/CFS, with potential links to inflammatory processes
Managing sleep-related difficulties may be therapeutically important for improving symptom burden in ME/CFS patients
Further research is needed to determine whether improving sleep quality reduces inflammation and improves outcomes, and to understand the underlying causes of sleep disruption in ME/CFS
Remaining Questions
What is the direction of causality—does poor sleep cause increased inflammation and symptoms, or do symptoms and inflammation cause poor sleep, or is there bidirectional causality?
What mechanisms drive sleep disturbance specifically in ME/CFS, and do they differ from sleep problems in other chronic illnesses?
Would interventions targeting sleep quality lead to improvements in inflammatory markers and symptom severity, and would such improvements be sustained?
What This Study Does Not Prove
This study demonstrates association, not causation—it does not prove that poor sleep causes inflammation or symptom worsening, only that they occur together. The cross-sectional design cannot establish the direction of effects; it is possible that severe symptoms and inflammation disrupt sleep, rather than sleep disruption driving inflammation. The findings apply specifically to women and may not generalize to men or other populations with ME/CFS.